MedTrace Logo

A Transtheoretical Model Group Therapy for Cocaine

NCT00178776 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 138

Last updated 2017-01-11

No results posted yet for this study

Summary

The purpose of this study is to determine the feasibility and promise of a recently manualized group therapy based on the Transtheoretical Model for cocaine use disorders.

Conditions

  • Cocaine Use Disorders

Interventions

BEHAVIORAL

Transtheoretical Model Group Therapy

BEHAVIORAL

Education & Advice

Sponsors & Collaborators

  • The University of Texas Health Science Center, Houston

    collaborator OTHER

  • National Institute on Drug Abuse (NIDA)

    lead NIH

Principal Investigators

  • Mary Marden Velasquez, Ph.D. · University of Texas Houston Medical School, Dept. of Family & Community Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-10-31
Primary Completion
2006-11-30
Completion
2007-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00178776 on ClinicalTrials.gov